written on 17.05.2019

Korea Pharma Report May 2019


One of the indisputable economic success stories of the last half century, South Korea now stands as the world’s 11th largest economy, with a reputation for industrial excellence and innovation. As the Korean state shifts its focus towards healthcare and the life sciences and Korean firms begin to internationalize with greater purpose, the attentions of the global investment community are being held evermore by a country that is thinking big.


This report covers the areas within the life sciences where Korea is garnering an increasingly strong international reputation, highlighting the country’s prowess in R&D and clinical trials, its thriving biotech ecosystem, and its growing footprint in the exciting field of regenerative medicine. Actors featured range from the heads of local biotechs, to association leaders, government officials, and the visionary CEOs spearheading the push of Korea’s large industrial conglomerates, or ‘Chaebols’, into the life sciences.

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here